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O B J E C T I V E S The purpose of this study was to evaluate the presence of myocardial ischemia
measured by adenosine stress cardiac magnetic resonance (CMR) using visual myocardial perfusion and
a quantitative myocardial perfusion reserve index (MPRI) in the absence of obstructive coronary artery
disease (CAD) in women with systemic lupus erythematosus (SLE) with anginal chest pain (CP).
B A C KG ROUND Ischemic heart disease is a leading cause of morbidity and mortality in SLE. Previous
studies demonstrated the presence of perfusion defects using adenosine stress CMR in patients with CP and
no obstructive CAD, consistent with microvascular coronary dysfunction in patients without SLE.
METHOD Twenty female SLE patients with typical and atypical anginal CP were prospectively
enrolled. Patients with established cardiovascular disease were excluded. CMR was performed with 0.05
mmol/kg gadolinium adenosine stress ﬁrst-pass perfusion in SLE patients and in 10 asymptomatic
reference control women. SLE patients also underwent 64-slice coronary computed tomography
angiography. CMR was scored visually and quantitatively (MPRI).
R E S U L T S Among 18 patients with complete data, no patient had obstructive CAD; however, 8 of 18
(44%) displayed visual perfusion defects on stress CMR compared with 0 in 10 control subjects (p 
0.014). The mean MPRI in patients versus controls was 2.0  0.4 versus 2.4  0.4 (p  0.031) in the
subepicardium and 1.8  0.3 versus 2.1  0.4 (p  0.24) in the subendocardium. Multivariate linear
regression revealed that SLE was the only predictor of subepicardial (p  0.0025;   1.059) and
subendocardial (p  0.05;   0.529) MPRIs.
CONC L U S I O N S We observed a 44% prevalence of abnormal stress myocardial perfusion by CMR
in the absence of obstructive CAD in SLE patients with anginal CP. Compared with controls, reduced
MPRI was observed in SLE patients, and SLE presence was a signiﬁcant predictor of an abnormal MPRI.
These ﬁndings are consistent with the hypothesis that anginal CP in SLE patients without obstructive
CAD is due to myocardial ischemia potentially caused by microvascular coronary dysfunction. Further
research in a larger SLE population is warranted. (J Am Coll Cardiol Img 2011;4:27–33) © 2011 by the
American College of Cardiology Foundation
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28schemic heart disease in systemic lupus erythemato-
sus (SLE) patients, a leading cause of morbidity and
mortality, has a complex pathogenesis that is in-
completely understood. Because SLE occurs primar-
ly in women, it is reasonable to explore whether
ertain features of ischemic heart disease seen in
omen may play an important role in SLE patients.
f women with acute ST-segment elevation myocar-
ial infarction, 10% to 25% do not have obstructive
oronary artery disease (CAD) on coronary angiogra-
hy (1). Microvascular coronary dysfunction is preva-
See page 34
ent in women with evidence of ischemia but without
bstructive CAD (2). Although these women were
riginally described as having cardiac syndrome X,
elieved to be a benign condition, contemporary
eports document that the presence of microvascular
oronary dysfunction and myocardial ischemia has an
adverse prognosis (1–4).
Adenosine cardiac magnetic resonance
(CMR) can detect stress-induced abnor-
mal hypoperfusion in women with signs
and symptoms of ischemia with no ob-
structive CAD (5,6). We initiated a pilot
study to evaluate myocardial ischemia us-
ing visual myocardial perfusion and a
myocardial perfusion reserve index
(MPRI) in a prospective sample of women
with SLE with anginal chest pain (CP)
and in a reference control population to
test the hypothesis that CP in SLE pa-
tients without obstructive CAD is due to
yocardial ischemia potentially caused by micro-
ascular coronary dysfunction.
A T E R I A L S A N D M E T H O D S
his study was approved by the institutional review
oard at Cedars-Sinai Medical Center, and all
articipants gave informed consent before study
articipation.
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hy
nanuscript received May 24, 2010; revised manuscript received September 3atients. Consecutive female patients presenting to
n SLE specialty practice who were 18 years of age
nd older and meeting revised American College of
heumatology criteria for SLE were invited to
articipate if they reported typical and atypical
nginal CP within the previous 6 months (7).
atients with established cardiovascular disease
ere excluded including a history of myocardial
nfarction, coronary artery stenting or bypass sur-
ery, angiographically documented CAD (70%
tenosis), as well as current pregnancy, allergy to
adiocontrast, baseline glomerular filtration rate
60 ml/min, or the inability to tolerate undergoing
MR or coronary computed tomography angiog-
aphy (CTA). Finally, participants with known
trial fibrillation, atrial flutter, and tachyarrhyth-
ias were excluded because arrhythmia can inter-
ere with accurate imaging of the coronary vascula-
ure with coronary CTA.
linical data collection. Study patients completed a
uestionnaire to collect information regarding age,
uration of SLE, SLE medication use during the
ast year, and traditional risk factors for CAD. On
creening physical examination, the patient’s body
ass index and systolic and diastolic blood pres-
ures were recorded. The 10-year Framingham risk
core was calculated for all SLE patients. Patients
ere evaluated for CP with a brief, standardized
ymptom questionnaire asking whether they had
ad pain or discomfort above the waist within the
ast 12 months, although patients were enrolled
nly if the CP occurred in the past 6 months (8).
he questionnaire also asked questions to assess the
resence of substernal pain, precipitating factors of
xertion or emotional stress, and/or relief within 10
in by rest or nitroglycerin to characterize the CP
s typical or atypical angina. Laboratory values
ollected included antinuclear antibody titer, other
utoantibody titers, complement levels, fasting lipid
anel, fasting glucose level, and estimated glomer-
lar filtration rate. A urine sample was obtained to
ule out pregnancy. The SLE Disease Activity
ndex (SLEDAI) was calculated for all SLE pa-
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29ients based on history, examination results, and
aboratory data (9).
MR. Adenosine stress/rest CMR and 64-slice cor-
nary CTA were performed at Cedars-Sinai Med-
cal Center. CMR at 1.5-T (Siemens Sonata, Er-
angen, Germany) using electrocardiographic gating
nd a phased-array coil was performed using a
tandardized protocol with 0.05 mmol/kg gadolin-
um first-pass perfusion 3-slice stress (adenosine
40 g/kg1/min1) followed by rest imaging,
unction, and delayed enhancement imaging. In 2
atients with a remote history of asthma, regade-
oson, an equivalent stress agent, was substituted
or adenosine. CMR was analyzed using visual
-point /16- (perfusion) or 17- (wall motion and
car) segment scoring system: 0, normal; 1, mildly
educed/equivocal; 2, moderately reduced; 3, severely
educed; 4, absent perfusion. Perfusion scores were
sed to calculate an estimated percentage of abnormal
yocardium by taking the sum of the severity scores
ivided by 64, which is the product of the number of
egments analyzed (16 segments), and the worst up-
ake score of 4 (10,11). Any stress perfusion defect size
5% was considered significant.
First-pass perfusion images were separately ana-
yzed using CAAS MRV CMR analysis software,
ersion 3.3 (Pie Medical Imaging B.V, Maastricht,
he Netherlands). Epicardial and endocardial con-
ours of the left ventricular myocardium were ap-
lied to the 3 slices in short-axis (basal, mid-, and
pical) and intensity-over-time curves generated for
est and stress perfusion. Intensity-over-time curves
ere used to calculate the relative upslope defined
s the ratio between the maximum upslope of the
elected curve divided by the maximum upslope of
he left ventricular cavity curve. Subendocardial and
ubepicardial MPRIs were calculated as the ratio of
he relative upslope at stress/relative upslope at rest.
he subendocardial region was established as the
nner 50% of the volume between the epicardial and
ndocardial contours. Internal assessment has
hown high intraobserver and interobserver repro-
ucibility of the MPRI in our group, with the
ighest correlation in mid-myocardial segments.
he interobserver reproducibility resulted in an
ntraclass correlation coefficient ranging from 0.72
o 0.85 in individual segments, and for intraobserver
eproducibility, it ranged from 0.89 to 0.92.
oronary CTA protocol and interpretation. Coronary
TA was performed using a 64-slice dual-source
canner (Definition, Siemens Medical Systems,
orchheim, Germany). To optimize imaging, par-icipants without contraindication received - mlockade with oral and/or intravenous metoprolol
o slow the heart rate to between 60 and 70
eats/min. An optimized dose modulation ap-
roach using helical acquisition and reduced voltage
as used to decrease radiation exposure (12). Indi-
iduals with compromised renal function on screen-
ng laboratory testing had 48-h interval between
MR and coronary CTA. Coronary CTA was read
y consensus of 2 imaging cardiologists who re-
orted the following: 1) the coronary artery calcium
core; and 2) the type (calcified, noncalcified,
ixed) and location of each coronary plaque as well
s the degree of coronary luminal narrowing using a
-point scale (25%, 25% to 49%, 50% to 69%,
0% to 89%, and 90%) (13). For dichotomous
lassification, coronary CTA was considered to
eveal abnormal findings if there was any visualized
oronary plaque (calcified, mixed, or noncalcified),
egardless of the degree of coronary narrowing.
ontrol sample. An asymptomatic reference control
roup of 10 women without evidence of CAD by
istory, risk factor assessment, and exercise tread-
ill stress testing was identified for comparison
nalysis. Reference control subjects were recruited
sing the medical center’s e-mail broadcast ex-
hange and self-identified as not having SLE or
eart disease risk factors such as hypertension,
yperlipidemia, and diabetes. All reference control
omen underwent a standard Bruce exercise tread-
ill test without signs or symptoms of ischemia
efore completing CMR.
tatistical analyses. For comparison of the MPRI
etween SLE patients and controls, Wilcoxon
ank-sum test was applied. Correlations were mea-
ured by Spearman rank correlation coefficients.
nivariate and multivariate linear regression analy-
es were performed with the MPRI and the pres-
nce of SLE and other potential risk variables.
p value 0.05 was considered statistically sig-
ificant. All statistical analyses were performed
sing SAS 9.1 (SAS Institute Inc., Cary, North
arolina).
E S U L T S
total of 20 female SLE patients with CP were
nrolled. All patients underwent coronary CTA, and
9 of 20 patients underwent stress CMR. The CMR
ata were unsuitable for analysis in 1 patient, leaving
8 of 20 patients for analysis of the MPRI.
atient characteristics. The baseline clinical and lab-
ratory characteristics of all 20 study patients are
hown in Table 1, including serologic results. The
ean age of SLE patients was 40.6 11 years with an
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30verage disease duration of 12.8 years and average
ody mass index of 25.8 kg/m2. All SLE patients were
ntinuclear antibody positive, and 55% had a positive
ouble-stranded deoxyribonucleic acid antibody. Risk
actors for CAD are shown in Table 2. The 10-year
ramingham risk score was 2% per year in 1 subject
nd 1% per year in the remaining study subjects
Table 3) (14). The reference control population
onsisted of 10 asymptomatic women who had no
istory of SLE, smoking, diabetes mellitus, hyperten-
ion, or hyperlipidemia and who completed a negative
igh workload Bruce protocol exercise tolerance test.
he mean age of controls was 53.2  5 years, which
as significantly different from the study subjects with
LE (p  0.001).
oronary CTA results. Eighteen female SLE patients
ith anginal CP had complete data and were used for
nalysis. In this group, the SLEDAI score was 0 in 3
atients, 1 to 5 (mild) in 10 patients, and 6 to 10
moderate) in 5 patients. Two SLE patients had mild
oronary atherosclerosis (isolated noncalcified plaque
ith 25% to 49% stenosis in the left anterior descend-
ng coronary artery in 1 patient and a coronary artery
alcium score of 5.9 in another patient, consistent with
inimal calcification), but no patient had obstructive
Table 1. Baseline Clinical and Laboratory Characteristics
Characteristic
Age, yrs 40.6
Female sex, n (%) 20 (100)
Duration of SLE, yrs (range) 12.8 (1–37)
Average SLE criteria (range) 4.85 (4–6)
Average body mass index, kg/m2 25.8
Corticosteroid use within past year, n (%) 16 (80)
Medication
Azathioprine 2 (10)
Hydroxychloroquine 12 (60)
Methotrexate 2 (10)
Nonsteroidal anti-inﬂammatory drugs 6 (30)
Mycophenolate mofetil 3 (15)
-blocker 1 (5)
Angiotensin receptor blocker 1 (5)
Baseline laboratory values
Positive antinuclear antibody, n (%) 20 (100)
Positive double-stranded DNA antibody, n (%) 11 (55)
Positive anti-Ro antibody, n (%) 5 (25)
Positive anti-La antibody, n (%) 2 (10)
Positive anti-Smith antibody, n (%) 4 (20)
Positive anticardiolipin IgG or IgM antibody, n (%) 1 (5)
Creatinine, mg/dl 0.7 0.14
Values are n, n (%), or n (range).
DNA  deoxyribonucleic acid; SLE  systemic lupus erythematosus.AD by coronary CTA (Table 3).MR results. All patients and controls had normal
ardiac structure and left ventricular systolic function
n CMR. There were 2 SLE patients who had a
istory of asthma who received regadenoson instead of
denosine. There was no patient or control with
elayed enhancement to suggest the presence of myo-
ardial scarring. On CMR, stress-induced hypoperfu-
ion was seen by semiquantitative visual analysis in 8
f 18 (44%; 95% confidence interval: 21.5% to 67.4%)
LE patients compared with 0 of 10 of the reference
ontrol group (Fisher exact test p value  0.014). In
ll 8 patients with visual perfusion abnormalities, the
attern seen was one of circumferential subendocar-
ial hypoperfusion (Fig. 1), predominantly in the
id-left ventricular slice. Both subjects with any
oronary CTA abnormality demonstrated circumfer-
ntial subendocardial myocardial perfusion defects on
MR (28% in the patient with noncalcified plaque
nd 9% in the patient with coronary calcium), not
orresponding to a coronary vascular territory. The
ean MPRI in patients versus controls was 2.0 0.4
ersus 2.3  0.4 (p  0.16); 2.0  0.4 versus 2.4 
.4 in the subepicardium (p  0.031) and 1.8  0.3
ersus 2.1  0.4 in the subendocardium (p  0.24).
epeating the visual and quantitative CMR analyses
fter exclusion of the 1 subject with an intermediate
tenosis did not change the results
There was no correlation between the MPRI and
LEDAI or SLE duration. Multivariate linear regres-
ion revealed that the presence of SLE was the only
redictor of subepicardial (p  0.0025,   1.059)
nd subendocardial (p  0.05,   0.529) MPRI.
Table 2. Coronary Artery Disease Risk Factors
Risk Factor
Systolic blood pressure, mm Hg 115 11.5
Diastolic blood pressure, mm Hg 76 10
Smoking ever, n (%) 7 (35)
Smoking current, n (%) 1 (5)
Fasting plasma glucose, mg/dl 70.0 18.3
Total cholesterol, mg/dl 202.0 45.3
Triglycerides, mg/dl 111.0 67.6
High-density lipoprotein, mg/dl 66.0 16.8
Low-density lipoprotein, mg/dl 114.0 41.9
Use of a cholesterol-lowering agent 1 (5)
History of blood clot 3 (15)
Family history of stroke 3 (15)
Family history of premature
coronary artery disease
4 (20)
Post-menopause 6 (30)
Hormone replacement therapy 6 (30)
History of arrhythmia 6 (30)Values are mean  SD or n (%).
DI
C
s
d
n
s
d
t
i
s
a
t
c
s
fi
w
s
p
c
h
p
s
t
n
n
s
c
d
a
a
b
a
a
t
d
o
i
e
S
d
m
s
e
T
o
a
m
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 1 , 2 0 1 1
J A N U A R Y 2 0 1 1 : 2 7 – 3 3
Ishimori et al.
CMR in SLE
31I S C U S S I O N
n this initial study of 18 female SLE patients with
P and low-to-moderate SLE disease activity, 44% of
tudy patients had visually abnormal adenosine CMR
espite a low prevalence of coronary atherosclerosis,
o obstructive CAD, and preservation of myocardial
tructure and function. The pattern of visual perfusion
efect was circumferential and subendocardial in all
he patients with abnormal results. Unlike adenosine-
nduced perfusion defects seen in CAD, which corre-
pond to the territory supplied by stenosed coronary
rteries, this circumferential subendocardial distribu-
ion of hypoperfusion does not correspond to a vas-
ular territory. Only 1 SLE patient had a 25% to 49%
tenosis noted on coronary CTA and abnormal CMR
ndings. This degree of stenosis is rarely associated
ith ischemia, and, importantly, the circumferential
ubendocardial distribution of the abnormality in this
atient is not consistent with left descending anterior
oronary artery ischemia (15). The circumferential
ypoperfusion pattern that we observed visually ap-
ears to be the same as that described in cardiac
yndrome X and attributed to microvascular dysfunc-
ion (6,16). Because our findings show that the ab-
ormal CMR perfusion pattern is circumferential and
ot associated with coronary atherosclerosis or ob-
tructive CAD, the findings may be due to microvas-
ular disease, as previously described in cardiac syn-
rome X.
Ischemic heart disease morbidity and mortality
mong SLE patients are prevalent, severe, accelerated,
nd a leading health care issue for this population. A
imodal mortality distribution has been described
mong SLE patients: those patients who die soon
fter diagnosis usually die of infections or complica-
ions of the disease itself; later in the course of the
isease, 48% die of ischemic heart disease (17). The
Table 3. Subjects With Reversible Perfusion Defects on CMR
Subject Age (yrs)
Framingham
Risk Score (%)* Perfu
2 59 1 M
3 39 1 S
8 52 1 S
9 52 1 S
10 54 1 S
11 47 2 S
13 43 1 S
19 35 1 S
*10-year risk of acute myocardial infarction or death.
CMR  cardiac magnetic resonance; CTA  computed tomography angiograp
fraction.verall mortality of SLE has recently improved, yetschemic heart disease remains a major factor influ-
ncing the pattern of morbidity and mortality (18,19).
LE patients with CP often present a diagnostic
ilemma; they are frequently told that they have
yofascial pain, chest wall pain, pericardial pain, or, in
ome cases, psychosomatic pain when standard cardiac
valuation testing does not identify obstructive CAD.
he current study suggests that SLE patients without
bstructive CAD have a high prevalence of CMR
bnormal findings consistent with myocardial ische-
ia, potentially due to microvascular coronary dys-
Figure 1. Rest and Stress Perfusion Images on Cardiac Magnetic
Illustrations of ﬁrst-pass, rest (left) and stress (right) perfusion imag
2-chamber views demonstrating normal myocardial enhancement a
cumferential area of subendocardial hypoperfusion (arrows) during
erity of
Defect (%) Coronary CTA Findings LVEF (%)
erate (9) Calcium score 5.9 63
re (14) Normal 69
re (28) LAD ulcerated plaque 49
re (16) Normal 66
re (14) Normal 60
re (38) Normal 70
re (21) Normal 64
re (16) Normal 64
AD  left anterior descending coronary artery; LVEF  left ventricular ejectionResonance
es through short-axis
t rest (A) and cir-
stress (B). C and DSev
sion
od
eve
eve
eve
eve
eve
eve
eve
hy; Loutline the anatomy of right ventricle (RV) and left ventricle (LV).
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32unction (2,20,21). Notably, our SLE patients were a
ow-risk population when assessed for traditional
AD risk factors, such as cholesterol levels, blood
ressure, and smoking status, and had low Framing-
am risk scores.
The Framingham risk score has been validated in
redicting cardiovascular risk among the general
opulation, but it has been shown to underestimate
he prevalence of cardiovascular risk in SLE pa-
ients (14,22). It has been observed that assessment
f coronary artery calcification by computed tomog-
aphy may be more effective than the Framingham
isk score in SLE patients (22). The absence of
therosclerosis and obstructive CAD by coronary
TA in almost all our study patients combined
ith a high prevalence of stress-induced myocardial
erfusion defects by CMR supports our hypothesis
hat anginal CP in SLE patients without obstruc-
ive CAD is due to myocardial ischemia potentially
aused by microvascular coronary dysfunction.
Coronary CTA and adenosine CMR were used
n our study. Coronary CTA is capable of assessing
laque volume and composition as well as the
resence of positive remodeling within the arterial
all; it is validated compared with both invasive
oronary angiography and histological coronary dis-
ase on autopsy (23). Adenosine CMR is a vali-
ated noninvasive method for the detection of
cclusive CAD and for the demonstration of ab-
ormal coronary flow reserve in a variety of reported
ettings (24). Previous work demonstrated that
MR findings are abnormal in the population of
atients with persistent CP, with evidence of ische-
ia but no obstructive CAD (6). In patients with
linically worrisome cardiac symptoms (angina,
yncope, arrhythmias), negative CMR findings
ave been reported to have a negative predictive
alue of 99.1% for major adverse cardiac events in 1
ear (25). Because coronary CTA and CMR eval-
ate differing aspects of ischemic heart disease (e.g.,
therosclerosis and obstructive CAD vs. myocardial
lood flow and myocardial perfusion, respectively),
e used these methods to help delineate better the
resumed complex, multifactorial pathogenesis of
AD in SLE patients. In addition to semiquanti-
ative visual analysis in our study, we also used a
uantitative analysis similar to that reported by
anting et al. (6). In our study, the SLE patients
lso had a significantly reduced mean subepicardial
uantitative MPRI compared with a reference con-
rol group, and only SLE predicted an abnormal
PRI. Unlike the study of Panting et al. (6), our
tudy did not show an abnormal subendocardial iPRI. The cause of this difference from previous
esults is unclear and may be related to the small
ample size of our study.
tudy limitations. Interpretation of these initial
ndings is limited by aspects of study design and
eneralizability of our results. We used a conve-
ience reference control sample of patients without
LE that was not age matched. Our SLE patient
roup had very low traditional cardiac risk factors,
imilar to the control sample. Further, our visual
eadings of CMR and coronary CTA in our SLE
opulation were not performed in a blinded man-
er, although the visual reading of the reference
ontrols and quantitative CMR analyses in both
opulations were. Although our sample size is
mall, the presence of stress-induced hypoperfusion
n almost half of the study subjects is of great
nterest because it may indicate a high prevalence of
yocardial ischemia potentially due to microvascu-
ar coronary dysfunction in SLE patients with CP
ot caused by obstructive CAD. The segmental
coring system for perfusion used a range of 0 to 4,
hich may exceed the detectable grades of hypo-
erfusion. This may have resulted in an overestima-
ion of the magnitude of the perfusion defects.
lthough we did not have age-matched reference
ontrols, the older age among our control subjects
ould be expected to reduce our likelihood of
nding the group differences that we describe,
uggesting that our results are true differences.
Future work could include a separate reference
ontrol population with CAD risk factors similar to
hose of the SLE subjects but without SLE to
urther support our findings. CMR results have
een correlated with coronary angiography results
n patients without SLE, but not yet in SLE
atients (26). In addition to further validation
esting with masked readings in SLE patients,
MR techniques will need additional standardiza-
ion procedures for reproducibility.
O N C L U S I O N S
n summary, among SLE patients with anginal CP
ut no obstructive CAD, we observed a 44% prev-
lence of abnormal stress myocardial perfusion by
MR and a reduced MPRI compared with refer-
nce control subjects; SLE presence was a signifi-
ant predictor of an abnormal MPRI. These find-
ngs are consistent with the hypothesis that anginal
P in SLE patients without obstructive CAD is
ue to myocardial ischemia potentially caused by
icrovascular coronary dysfunction. Further studys warranted to validate these initial findings by
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hysiological pathways and prognostic significance630 – 40.
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